American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on surgeon practice patterns

Annals of Surgical Oncology

Volumn 19, Issue 10, 2012, Pages 3144-3151

  Caudle, Abigail S ^a   Hunt, Kelly K ^a   Tucker, Susan L ^a   Hoffman, Karen ^a   Gainer, Sarah M ^a   Lucci, Anthony ^a   Kuerer, Henry M ^a   Meric Bernstam, Funda ^a   Shah, Ruchita ^a   Babiera, Gildy V ^a   Sahin, Aysegul A ^a   Mittendorf, Elizabeth A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CLINICAL ASSESSMENT; CLINICAL PRACTICE; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; MEDICAL SPECIALIST; ONCOLOGY; OPERATION DURATION; PARTIAL MASTECTOMY; POSTMENOPAUSE; PREMENOPAUSE; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE METASTASIS; SURGEON; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COHORT STUDIES; DECISION MAKING; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SOCIETIES, MEDICAL;

EID: 84868199524     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2531-z     Document Type: Article

References (22)

1. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312(11):665-73. (Pubitemid 15134702)
2. Giuliano A, Kirgan D, Guenther J, Morton D. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220(3):391-9.
3. Giuliano A, Dale P, Turner R, Morton D, Evans S, Krasne D. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222(3):394-9.
4. National Comprehensive Cancer Network (NCCN) Clinical practice guidelines in oncology: breast. version 2.2008; 2008.
5. Lyman G, Giuliano A, Somerfield M, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2006; 24(1):210-1.
6. Yi M, Giordano S, Meric-Bernstam F, et al. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol. 2010;17(Suppl 3).
7. Bilimoria K, Bentrem D, Hansen N, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol. 2009; 27(18):2946-53.
8. Hwang R, Gonzalez-Angulo A, Yi M, et al. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer. 2007;110(4):723-30. (Pubitemid 47257646)
9. Giuliano A, Hunt K, Ballman K, et al. Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis. JAMA. 2011;305(6):569-75.
10. Giuliano A, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252(3):426-32.
11. Morrow M, Giuliano A. To cut is to cure: can we really apply Z11 in practice? Ann Surg Oncol. 2011;18(9):2413-5.
12. Caudle A, Hunt K, Kuerer H, et al. Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial. Ann Surg Oncol. 2011;19(8):2407-12.
13. National Comprehensive Cancer Network (NCCN) Clinical practice guidelines in oncology: breast, Version 2011; 2011.
14. National Comprehensive Cancer Network (NCCN) Clinical practice guidelines in oncology: breast, Version 2012; 2012.
15. Krishnamurthy S, Sneige N, Bedi D, et al. Role of ultrasoundguided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer. 2002;95(5):982-8. (Pubitemid 34925346)
16. Mittendorf E, Hunt K, Boughey J, et al. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg. 2012;255(1):109-15.
17. Setton J, Cody H, Tan L, et al. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection. Cancer. 2011.
18. Haffty B, Hunt K, Harris J, Buchholz T. Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. J Clin Oncol. 2011;29(34):4479-81.
19. Mittendorf E, Sahin A, Tucker S, et al. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol. 2008;15(12): 3369-77.
20. Kim T, Guiuliano A, Lyman G. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106(1):4-16. (Pubitemid 43033320)
21. Lucci A, McCall L, Beitsch P, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25(24):3657-63. (Pubitemid 47372604)
22. Shih Y, Xu Y, Cormier J, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27(12):2007-14.